Tekla Capital Management’s Novavax NVAX Stock Holding History

Tekla Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$474K	Hold	63,800	–	–	0.02%	146
2023 Q1	$442K	Hold	63,800	–	–	0.02%	153
2022 Q4	$656K	Hold	63,800	–	–	0.02%	141
2022 Q3	$1.16M	Hold	63,800	–	–	0.05%	130
2022 Q2	$3.28M	Hold	63,800	–	–	0.13%	100
2022 Q1	$4.7M	Hold	63,800	–	–	0.17%	97
2021 Q4	$9.13M	Sell	63,800 -87,691	-58%	-$15.1M	0.29%	75
2021 Q3	$31.4M	Buy	151,491 +63,895	+73%	+$14.1M	1.01%	31
2021 Q2	$18.6M	Sell	87,596 -17,580	-17%	-$3.22M	0.6%	46
2021 Q1	$19.1M	Buy	105,176 +28,591	+37%	+$5.7M	0.66%	40
2020 Q4	$8.54M	Buy	76,585 +65,062	+565%	+$6.92M	0.3%	92
2020 Q3	$1.25M	Sell	11,523 -17,027	-60%	-$2.07M	0.05%	171
2020 Q2	$2.38M	Hold	28,550	–	–	0.09%	154
2020 Q1	$388K	Hold	28,550	–	–	0.02%	202
2019 Q4	$114K	Hold	28,550	–	–	﹤0.01%	210
2019 Q3	$143K	Hold	28,550	–	–	0.01%	185
2019 Q2	$167K	Hold	28,550	–	–	0.01%	192
2019 Q1	$315K	Hold	28,550	–	–	0.01%	185
2018 Q4	$1.05M	Hold	28,550	–	–	0.05%	163
2018 Q3	$1.07M	Hold	28,550	–	–	0.04%	181
2018 Q2	$765K	Hold	28,550	–	–	0.03%	163
2018 Q1	$1.2M	Hold	28,550	–	–	0.05%	155
2017 Q4	$708K	Hold	28,550	–	–	0.03%	149
2017 Q3	$651K	Hold	28,550	–	–	0.02%	141
2017 Q2	$657K	Hold	28,550	–	–	0.02%	132
2017 Q1	$731K	Hold	28,550	–	–	0.03%	129
2016 Q4	$719K	Hold	28,550	–	–	0.03%	135
2016 Q3	$1.19M	Buy	28,550 +10,650	+59%	+$1.37M	0.05%	133
2016 Q2	$2.6M	Hold	17,900	–	–	0.11%	121
2016 Q1	$1.85M	Hold	17,900	–	–	0.08%	124
2015 Q4	$3M	Buy	+17,900	New	+$2.75M	0.11%	105

Other funds holding NVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tekla Capital Management's NVAX Position: Q2 2023 in Review

Tekla Capital Management held its Novavax (NVAX) position steady in Q2 2023 at 63,800 shares worth $474K. The position accounts for 0.02% of the portfolio, ranked #146.

Tekla Capital Management first reported a position in NVAX in Q4 2015 and has held it in 31 quarters since. The position peaked at $31.4M in Q3 2021. 216 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.

Tekla Capital Management held 63,800 shares of Novavax worth $474K as of Q2 2023.
Tekla Capital Management left its Novavax share count unchanged in Q2 2023.
Novavax made up 0.02% of Tekla Capital Management's portfolio in Q2 2023, its #146 holding.
Tekla Capital Management first reported a position in Novavax in Q4 2015 and has held it in 31 quarters since.
Tekla Capital Management's Novavax position peaked at $31.4M in Q3 2021.
216 funds tracked by Wall St. Rank held Novavax as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.